Skip to main content
Qiagen N.V. logo

Qiagen N.V. — Investor Relations & Filings

Ticker · QIA ISIN · NL0015001WM6 LEI · 54930036WK3GMCN17Z57 F Manufacturing
Open in API
Filings indexed 626 across all filing types
Latest filing 2020-05-07 Regulatory Filings
Country NL Netherlands
Listing F QIA

About Qiagen N.V.

https://www.qiagen.com/

Qiagen N.V. is a global provider of "Sample to Insight" solutions, offering technologies that transform biological materials into valuable molecular insights. The company develops and markets sample and assay technologies, automated instrumentation, and bioinformatics software for molecular diagnostics, applied testing, academic research, and pharmaceutical development. Its comprehensive portfolio supports the entire workflow from sample collection and preparation of DNA, RNA, and proteins to analysis and interpretation. Key product areas include sample preparation kits, PCR, digital PCR (dPCR), and next-generation sequencing (NGS) solutions, as well as syndromic testing panels for infectious diseases.

Recent filings

Filing Released Lang Actions
6-K
Regulatory Filings
2020-05-07 English
6-K
Regulatory Filings
2020-05-07 English
QIAGEN reports full results for first quarter of 2020
Earnings Release Classification · 100% confidence The document is titled "QIAGEN reports full results for first quarter of 2020" and contains detailed financial tables for Q1 2020 compared to Q1 2019, including Net sales, Operating income, EPS, Balance sheet, and Cash flows. It explicitly discusses period-specific financial performance and outlook. This structure is characteristic of a comprehensive financial report covering a period shorter than a full year. Since it covers the first quarter (Q1), it fits the definition of an Interim / Quarterly Report (IR). It is not an Earnings Release (ER) because it provides full, detailed results and tables, not just highlights. It is also not a 10-K (Annual Report) as it covers only one quarter. Q1 2020
2020-05-07 English
6-K
Regulatory Filings
2020-05-06 English
QIAGEN expects higher results for Q2 2020 based on trends to date and suspends outlook for full-year 2020
Earnings Release Classification · 100% confidence The document is a press release dated May 5, 2020, titled "QIAGEN expects higher results for Q2 2020 based on trends to date and suspends outlook for full-year 2020." It provides preliminary financial expectations (net sales growth, adjusted EPS) for the upcoming second quarter and announces the suspension of the full-year outlook due to COVID-19 uncertainties. This content—a preliminary announcement of key financial figures before the official quarterly report—is the definition of an Earnings Release (ER). It is not a full comprehensive report (IR), a transcript (CT), or a proxy statement (PSI). Q2 2020
2020-05-06 English
QIAGEN expects higher results for Q2 2020 based on trends to date and suspends outlook for full-year 2020
Earnings Release Classification · 100% confidence The document is explicitly titled 'Ad hoc Announcement according to Art. 17 Market Abuse Regulation' and provides preliminary financial expectations ('QIAGEN expects higher results for Q2 2020') and suspends the full-year outlook. This type of immediate, material financial update, often released outside of scheduled reporting periods, is characteristic of an Earnings Release (ER) or a general regulatory announcement. Since it is an ad hoc announcement concerning expected financial results (sales growth, EPS), it fits best under the Earnings Release (ER) category, which covers the initial announcement of periodical financial results (even if preliminary or revised). It is not a full 10-K, a transcript (CT), or a formal dividend notice (DIV). Given the nature of the announcement (preliminary results update), ER is the most appropriate fit, although RNS could also apply as a fallback for ad hoc regulatory news. Q2 2020
2020-05-06 English

Browse filings by year

29 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.